Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
fda
pfizer
startups
vertex pharmaceuticals
biotech ipos
cancer immunotherapy
cystic fibrosis
deals
drugs
What
bio
5
×
roundup
drug
fda
growing
advantages
ahead
alliance
alzheimer’s
annual
approved
asco
assessed
attention
bar
biotech
branded
brings
bristol
buy
calls
changing
choices
color
commissioner
communities
companies
conference
consumers
costly
counterweight
crispr
days
digital
disease
drugs
elevatebio
epidemic
esmo
europe
Language
unset
Current search:
investing
×
bio
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More